Clínic Barcelona
Clínic Barcelona
Research
November 20 2024
Research news
Featured news
Latest news
Clínic Barcelona
Clínic Barcelona
Research
December 5 2024
IDIBAPS hosts a meeting of experts on paediatric non-Hodgkin lymphoma
Clínic Barcelona
Clínic Barcelona
Research
December 3 2024
A Clínic-IDIBAPS team publishes an update on the most critical aspects of bipolar disorder
Clínic Barcelona
Clínic Barcelona
Research
November 29 2024
A new 3D model is developed to study mutations in epithelial tissues
Clínic Barcelona
Clínic Barcelona
Research
November 28 2024
Three European institutions visit IDIBAPS within the framework of the PANERIS project
Clínic Barcelona
Clínic Barcelona
Research
November 27 2024
Researchers at Clínic-IDIBAPS assess the use of artificial intelligence in the diagnosis of Lynch syndrome
Researchers from Hospital Clínic-IDIBAPS have coordinated a study comparing the efficacy of artificial intelligence-assisted colonoscopy versus high-1
Clínic Barcelona
Clínic Barcelona
Research
November 26 2024
IDIBAPS creates two new multidisciplinary research programs to promote collaboration between groups
They are Metabolism and disease programme (MetaDis) and Translational research programme for brain disorders
Clínic Barcelona
Clínic Barcelona
Research
November 25 2024
Nine Clínic-IDIBAPS projects funded by La Marató de TV3 on sexual and reproductive health
A total of nine projects led by or enjoying the participation of researchers at IDIBAPS-Hospital Clínic Barcelona have received over 2.3 million euro1
Clínic Barcelona
Clínic Barcelona
Research
November 22 2024
An MRI may predict the risk of ventricular tachycardia following cardiac ablation
A study conducted by IDIBAPS-Hospital Clínic Barcelona shows that an MRI after ventricular tachycardia ablation can detect a decrease in areas of car1
Clínic Barcelona
Clínic Barcelona
Research
November 20 2024
The Clínic-IDIBAPS confirms definitively that REM sleep disorder is the precursor of neurodegenerative diseases such as Parkinson’s disease
These findings offer a solid basis for designing clinical trials of therapies aimed at modifying the development of these neurodegenerative diseases1